Bilateral septic arthritis of the hip: Does etanercept play a role? A case report

被引：5

作者：

Amital, H ^{[1
]}

Aamar, S ^{[1
]}

Rubinow, A ^{[1
]}

机构：

[1] Hadassah Hebrew Univ, Sch Med, Div Internal Med, Rheumatol Unit, IL-91120 Jerusalem, Israel

来源：

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME | 2003年 / 85A卷 / 11期

关键词：

D O I：

10.2106/00004623-200311000-00023

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

[No abstract available]

引用

页码：2205 / 2206

页数：2

共 16 条

[1]

Antoni C, 2002, CLIN EXP RHEUMATOL, V20, pS152

[2]

*ARTHR ADV COMM, 2001, SAF UPD TNF A ANT IN

[3]

Baghai M, 2001, MAYO CLIN PROC, V76, P653

[4] Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases [J].

Criscione, LG ;

St Clair, EW .

CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (03) :204-211

[5] Newer immunosuppressive drugs - Their potential role in rheumatoid arthritis therapy [J].

Drosos, AA .

DRUGS, 2002, 62 (06) :891-907

[6] Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].

Feldmann, M ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196

[7] Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept [J].

Fleischmann, R ;

Iqbal, I ;

Nandeshwar, P ;

Quiceno, A .

DRUG SAFETY, 2002, 25 (03) :173-197

[8]

GORDON C, 1990, J IMMUNOL, V144, P1753

[9] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[10] Infliximab and methotrexate in the treatment of rheumatoid arthritis [J].

Lipsky, PE ;

van der Heijde, DMFM ;

St Clair, EW ;

Furst, DE ;

Breedveld, FC ;

Kalden, JR ;

Smolen, JS ;

Weisman, M ;

Emery, P ;

Feldmann, M ;

Harriman, GR ;

Maini, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1594-1602

← 1 2 →